Side effects, aftermath effects, nutrient depletions, drug and supplement interactions, and body support protocols for informed patient-provider conversation. This is educational information, not medical advice. All medication decisions — including any changes to dose or schedule — must be made with your prescribing physician.
This library does not include every drug. Entries are added on an ongoing basis — if you don't see what you're looking for, check back or reach out.
No one has ever had a pharmacology deficiency.
You can be deficient in magnesium, in sunlight, in sleep, in real food, in clean water, in meaningful connection. Every chronic disease has an underlying cause — and that cause is never a shortage of pharmaceuticals.
This library documents what each drug can do, what it can take from the body over time, and what questions to bring to your prescribing physician. Use it to walk into your next appointment informed.
Educational awareness only — not medical advice, diagnosis, or treatment. All medication decisions are directed by your prescribing physician.
No drugs found matching your search.
Select a drug from the list to view its full profile.
Going Deeper
Video Transcripts
The research and context behind this library — in Allie's own words.
Transcript
Studies published in the Journal of the American Medical Association — Starfield, 2000 — and the Journal of Patient Safety — James, 2013 — estimate that adverse drug events from correctly prescribed medications cause between 106,000 and 440,000 deaths per year in the United States. That places iatrogenic drug harm consistently among the top four leading causes of death in this country — alongside heart disease, cancer, and stroke.
I want to be clear about what those studies are saying: these are not overdoses. These are not errors. These are correctly prescribed medications, taken as directed, killing people at a rate we do not talk about.
And then there are drug mills — clinics run by physicians who prescribe controlled substances at high volume with minimal or no real medical oversight. Florida became the epicenter of the U.S. opioid crisis in the 2000s. Pill mills operated openly across the state. Patients drove from other states to get prescriptions. Before targeted enforcement began around 2010–2011, this was normalized. Despite legislative crackdowns, the pattern has continued in new forms.
I'm going to share some documented cases because I think when we see names and places, it becomes real in a way that statistics don't convey.
In 2025, federal prosecutors charged Dr. Sergei Margulian of Hallandale Beach with dispensing approximately 2.9 million oxycodone pills out of clinics in Broward and Miami-Dade counties between 2021 and 2024 — to patients he reportedly never examined. In Northwest Florida, Dr. Elaine Sharp of Gulf Breeze was arrested in October 2024 by FDLE for murder, manslaughter, and racketeering — a case that began after local pharmacists filed complaints about the sheer volume of oxycodone she was prescribing. Pace Pharmacy in the Santa Rosa area — owners arrested in 2025, charged with trafficking over 22 kilograms of oxycodone and 26 kilograms of hydrocodone.
And right here in the Pensacola area — active federal cases as of 2025 and 2026: four women charged with forging physician signatures and DEA registration numbers to illegally distribute over 300,000 hydrocodone and 30,000 oxycodone pills between 2015 and 2024. Two of those defendants pleaded guilty in November 2025. A Pensacola pharmacist faces trial in March 2026 on drug diversion conspiracy charges.
This is the backdrop for why this library exists. Not to scare you away from medication — but to give you the context your consent requires.
I want to talk about a pattern I've seen consistently in women with breast cancer — and I'm talking about a lot of women over a lot of years. Not in every case. But often enough that it became something I watch for.
It's not one substance. It's the long-term concurrent use of several everyday things — each one considered safe in isolation — whose combined estrogenic, inflammatory, and immune-suppressive burden accumulates over years on tissue that is estrogen-sensitive.
Here's what that pattern can look like. Chronic high caffeine intake — which in some studies stimulates proliferation of estrogen-sensitive breast tissue and alters sleep architecture and cortisol rhythm. Diphenhydramine, sold as Benadryl and in most sleep aids — anticholinergic, associated with increased breast cancer risk in long-term OTC use in a 2019 University of Washington study, and it disrupts the sleep cycles that allow melatonin to do its tumor-suppressive work.
Corticosteroid inhalers — the kind prescribed for asthma and allergies — with chronic use, create systemic immune suppression and suppress the cortisol axis; some research links long-term inhaled steroid use to elevated breast cancer risk. Cetirizine — Zyrtec — where emerging research suggests that antihistamines may block histamine's anti-tumor immune signaling in some cancers. Chronic NSAID use — which damages gut lining, alters microbiome composition, disrupts prostaglandin balance, and creates kidney burden that compounds hormonal clearance issues.
And oral contraceptives — which are a WHO Group 1 carcinogen. The IARC has confirmed elevated breast cancer risk with combined estrogen-progestin pills. That risk can persist up to 10 years after stopping, and it's higher with modern high-potency progestins.
No single substance causes cancer. That's not what I'm saying. What I'm asking is: what is the cumulative burden over years — hormonal, inflammatory, immune — on tissue that is already estrogen-sensitive? That is the question medicine is not trained to ask. But it's the one that matters.
See the Breast Health page for the full polypharmacy pattern and research citations.